Table 4.
30-Day Complications | Total Cohort n=303(100%) | Year < 2004 n=159 (52%) | Year ≥ 2004 n=144 (48%) | P |
---|---|---|---|---|
Urinary tract infection | 44 (15%) | 24 (15%) | 20 (14%) | .77 |
Pneumonia | 80 (26%) | 44 (28%) | 36 (25%) | .60 |
Myocardial infarction | 41 (14%) | 28 (18%) | 13 (9%) | .03 |
Clostridium difficile colitis | 19 (6%) | 11 (7%) | 8 (6%) | .63 |
Mortality | 185 (61%) | 102 (64%) | 83 (58%) | .25 |
Major adverse event, any | 191 (63%) | 100 (62%) | 91 (63%) | .96 |